Medical Therapy of Ulcerative Colitis (eBook)
XIV, 479 Seiten
Springer New York (Verlag)
978-1-4939-1677-1 (ISBN)
Gary R. Lichtenstein, MD
Professor of Medicine,
University of Pennsylvania School of Medicine,
Director, Center for Inflammatory Bowel Diseases
University of Pennsylvania Health System
Hospital of the University of Pennsylvania,
Gastroenterology Division,
Philadelphia, PA
USA
Medical Therapy of Ulcerative Colitis will serve as an invaluable resource for individual physicians use who treat patients with ulcerative colitis. The text presents a comprehensive overview of medical therapy for management of specific clinical scenarios and also a focus on the individual medications used to treat patients with ulcerative colitis. The book will be evidence based and focus on simplifying the current treatment to make it easy to understand. The chapters are written by experts in their fields and provide the most up to date information. This book will target gastroenterologists who focus on IBD, general gastroenterologists, fellows, and surgeons such as colorectal surgeons or GI surgeons who may treat patients with ulcerative colitis.
Gary R. Lichtenstein, MDProfessor of Medicine,University of Pennsylvania School of Medicine, Director, Center for Inflammatory Bowel DiseasesUniversity of Pennsylvania Health SystemHospital of the University of Pennsylvania, Gastroenterology Division, Philadelphia, PAUSA
Chapter 1 The History of Medical Therapy of Ulcerative Colitis Chapter 2 The Role of the Food and Drug Administration in Medical Therapy for Ulcerative Colitis Chapter 3 The Natural History of Ulcerative Colitis Chapter 4 Principles of Management of Ulcerative Colitis Chapter 5The Importance of Mucosal Healing in Ulcerative Colitis Chapter 6 Oral Mesalamine Chapter 7 Contrast and Comparison of Mesalamine Derivatives in the Treatment of Ulcerative Colitis Chapter 8 Topical Mesalamine Chapter 9 Oral and Parenteral Corticosteroid Therapy in Ulcerative Colitis Chapter 10 Rectal Glucocorticoid Use In Ulcerative Colitis Chapter 11 Antimetabolite Therapy in ulcerative colitis: Azathioprine, 6-Mercaptupurine and Methotrexate Chapter 12 Azathioprine / 6-Mercaptopurine Metabolism in Ulcerative Colitis: A Guide to Metabolite Assessment: An Evidence Based Approach Chapter 13 Cyclosporine for Ulcerative colitis Chapter 14 Tacrolimus, Sirolimus and Mycophenolate Mofetil Chapter 15 Infliximab for Ulcerative Colitis Chapter 16 Beyond Infliximab: Other anti-TNF therapies for Ulcerative Colitis Chapter 17 Novel Biologics for the Treatment of Ulcerative Colitis Chapter 18 Probiotics, Prebiotics, and Antibiotics for Ulcerative colitis Chapter 19 Novel NonBiologic Therapies for Ulcerative Colitis Chapter 20 Disease Modifiers in the Management of Ulcerative Colitis Chapter 21 Treatment of Ulcerative Proctitis Chapter 22 Treatment of Distal / Left Sided Ulcerative Colitis Chapter 23 Treatment of Severe Ulcerative Colitis Chapter 24 Pregnancy and Fertility in Ulcerative Colitis Chapter 25 Pediatric Issues in Treating Ulcerative Colitis Chapter 26 Chemoprevention in Ulcerative Colitis Chapter 27 Safety Considerations in the Medical Therapy of Ulcerative Colitis Chapter 28 Management of Steroid-Dependent and Steroid-Refractory Chapter 29 Medical Therapy of Ulcerative Colitis Chapter 30 Medication Adherence in Ulcerative Colitis Chapter 31 The Role of Telemedicine for Management of Ulcerative Colitis Chapter 32 Assessment of Disease Activity in Ulcerative Colitis Chapter 33 Medical Management of Toxic Megacolon Chapter 34 Management of Acute and Chronic Pouchitis Chapter 35 Medical Treatment of Extraintestinal Manifestation of Chapter 36 Mimics of Ulcerative Colitis Chapter 37 The role of diet and nutrition in ulcerative colitis Chapter 38 Parenteral Nutrition Use in Ulcerative Colitis Chapter 39 Maintenance of Remission in Ulcerative Colitis Chapter 40 Management of Irritable Bowel Syndrome in the Patient with Ulcerative ColitisChapter 41 Medical Treatment of Hepatobiliary Diseases Associated with Ulcerative Colitis Chapter 42Step-Up versus Top-Down Therapy in Ulcerative Colitis
| Erscheint lt. Verlag | 28.11.2014 |
|---|---|
| Zusatzinfo | XIV, 479 p. 50 illus., 27 illus. in color. |
| Verlagsort | New York |
| Sprache | englisch |
| Themenwelt | Medizinische Fachgebiete ► Chirurgie ► Viszeralchirurgie |
| Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie | |
| Schlagworte | Antiimetabolite therapy • Cyclosporine • Oral mesalamine • Parenteral corticosteroids • Topical mesalamine |
| ISBN-10 | 1-4939-1677-7 / 1493916777 |
| ISBN-13 | 978-1-4939-1677-1 / 9781493916771 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 9,0 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
